annual accounts payable:
$9.62M-$1.04M(-9.73%)Summary
- As of today (May 29, 2025), BBIO annual accounts payable is $9.62 million, with the most recent change of -$1.04 million (-9.73%) on December 31, 2024.
- During the last 3 years, BBIO annual accounts payable has fallen by -$2.27 million (-19.07%).
- BBIO annual accounts payable is now -28.80% below its all-time high of $13.51 million, reached on December 31, 2018.
Performance
BBIO Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$27.52M+$17.91M(+186.18%)Summary
- As of today (May 29, 2025), BBIO quarterly accounts payable is $27.52 million, with the most recent change of +$17.91 million (+186.18%) on March 31, 2025.
- Over the past year, BBIO quarterly accounts payable has increased by +$22.80 million (+482.17%).
- BBIO quarterly accounts payable is now at all-time high.
Performance
BBIO quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BBIO Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.7% | +482.2% |
| 3 y3 years | -19.1% | +172.3% |
| 5 y5 years | +8.7% | +110.3% |
BBIO Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.1% | at low | at high | +610.5% |
| 5 y | 5-year | -19.1% | +8.7% | at high | +610.5% |
| alltime | all time | -28.8% | +410.2% | at high | +610.5% |
BBIO Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $27.52M(+186.2%) |
| Dec 2024 | $9.62M(-9.7%) | $9.62M(-28.0%) |
| Sep 2024 | - | $13.36M(-26.3%) |
| Jun 2024 | - | $18.13M(+283.4%) |
| Mar 2024 | - | $4.73M(-55.6%) |
| Dec 2023 | $10.65M(-7.8%) | $10.65M(+138.3%) |
| Sep 2023 | - | $4.47M(+15.4%) |
| Jun 2023 | - | $3.87M(-5.0%) |
| Mar 2023 | - | $4.08M(-64.7%) |
| Dec 2022 | $11.56M(-2.7%) | $11.56M(+13.8%) |
| Sep 2022 | - | $10.16M(+15.5%) |
| Jun 2022 | - | $8.79M(-13.0%) |
| Mar 2022 | - | $10.11M(-15.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $11.88M(+32.9%) | $11.88M(-1.3%) |
| Sep 2021 | - | $12.04M(-46.1%) |
| Jun 2021 | - | $22.33M(+115.9%) |
| Mar 2021 | - | $10.34M(+15.6%) |
| Dec 2020 | $8.95M(+1.1%) | $8.95M(-9.1%) |
| Sep 2020 | - | $9.84M(-23.3%) |
| Jun 2020 | - | $12.84M(-1.9%) |
| Mar 2020 | - | $13.09M(+47.8%) |
| Dec 2019 | $8.85M(-34.5%) | $8.85M(-13.8%) |
| Sep 2019 | - | $10.27M(-36.1%) |
| Jun 2019 | - | $16.07M(+30.1%) |
| Mar 2019 | - | $12.34M(-8.6%) |
| Dec 2018 | $13.51M(+616.7%) | $13.51M |
| Dec 2017 | $1.89M | - |
FAQ
- What is BridgeBio Pharma annual accounts payable?
- What is the all time high annual accounts payable for BridgeBio Pharma?
- What is BridgeBio Pharma annual accounts payable year-on-year change?
- What is BridgeBio Pharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly accounts payable year-on-year change?
What is BridgeBio Pharma annual accounts payable?
The current annual accounts payable of BBIO is $9.62M
What is the all time high annual accounts payable for BridgeBio Pharma?
BridgeBio Pharma all-time high annual accounts payable is $13.51M
What is BridgeBio Pharma annual accounts payable year-on-year change?
Over the past year, BBIO annual accounts payable has changed by -$1.04M (-9.73%)
What is BridgeBio Pharma quarterly accounts payable?
The current quarterly accounts payable of BBIO is $27.52M
What is the all time high quarterly accounts payable for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly accounts payable is $27.52M
What is BridgeBio Pharma quarterly accounts payable year-on-year change?
Over the past year, BBIO quarterly accounts payable has changed by +$22.80M (+482.17%)